Evaluate the Key & Niche Companies Operating in the World's Drug Discovery Technologies Industry.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c41074) has announced the addition of Drug Discovery Technologies - Global Strategic Business Report to their offering.

This report analyzes the worldwide markets for Drug Discovery Technologies in Millions of US$. The specific technology types analyzed are Bioanalytical Instruments, High Throughput Screening (HTS), Biochip, Proteomics, Genomics, Bioinformatics, and Pharmacogenomics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2010. The report profiles 134 companies including many key and niche players worldwide such as Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc., Albany Molecular Research, Inc., Amersham Biosciences, Applera Corporation, ArQule Inc., AstraZeneca, BD Biosciences, Bio-Rad Laboratories, Inc., BioSciences Group, Caliper Life Sciences, Inc., Capital GenomiX, Caprion Pharmaceuticals Inc., Charles River Laboratories International, Inc., ChemBridge Corporation, deCODE Genetics, Inc., Discovery Partners International Inc., Evotec AG, ICOS Corporation, Incyte Corporation, Inpharmatica, Invitrogen Corporation, Medarex, Inc., Merck & Co., Inc., Millennium Pharmaceuticals, Inc., National Center for Drug Screening, PerkinElmer, Inc., Pharmacopeia Drug Discovery, Inc., Proteome Systems, Quantum Pharmaceuticals, Shimadzu Corporation, Sigma-Aldrich, Tecan Group, and Tripos, Inc.

Topics Covered

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

1. Industry Overview

2. Market Trends

3. Drug Discovery

4. Product Launches

5. Recent Industry Activity

6. Focus on Select Global Players

7. Global Market Perspective

II. MARKET

1. The United States

2. Canada

3. Japan

4. Europe

5. Rest of World

III. COMPETITION

Companies Mentioned Include:

- 3DM, Inc (USA) - Abbott Laboratories (USA) - ACADIA Pharmaceuticals, Inc (USA) - Advion Biosciences, Inc (USA) - Affymax, Inc (USA) - Affymetrix, Inc (USA) - Agilent Technologies, Inc (USA) - Albany Molecular Research, Inc (USA) - Alnis Biosciences, Inc (USA) - Alnylam Pharmaceuticals, Inc (USA) - Anadys Pharmaceuticals (USA) - Analytik Jena AG (Germany) - ANP Technologies, Inc (USA) - Apath LLC (USA) - Applera Corporation (USA) - Archemix Corporation (USA) - Arena Pharmaceuticals, Inc (USA) - Array BioPharma, Inc (USA) - AstraZeneca PLC (UK) - Bioanalytical Systems, Inc (USA)- BD Biosciences (USA) - Beckman Coulter, Inc (USA) - Benitec Ltd (Australia) - Berthod Technologies GmbH & Co (Germany) - Biacore International AB (Sweden) - BioCrystal Limited (USA) - BioForce Nanosciences, Inc (USA) - BioImagene, Inc (USA) - Bio-Rad Laboratories, Inc (USA) - Bioscan, Inc (USA) - BioSciences Group (USA) - Biotech India (India) - Bio-Tek Instruments, Inc (USA) - BioTrove, Inc (USA) - Bristol-Myers Squibb Company (USA) - Caliper Life Sciences, Inc (USA) - Cambridge Antibody Technology (UK) - Capital Genomix (USA) - CapitalBio Corporation (China) - Caprion Pharmaceuticals, Inc (Canada) - Cellomics, Inc (USA) - Cenix BioScience GmbH (Germany) - Cerep (France) - Cetek Corporation (USA) - CGI Pharmaceuticals, Inc (USA) - Charles River Laboratories (USA) - ChemBridge Corporation (USA) - ChemDiv, Inc (USA) - Chugai Pharmaceutical Co, Ltd (Japan) - CombiMatrix Corporation (USA) - Compugen USA, Inc (USA) - CrystalPlex Corporation (USA) - Cytokinetics, Inc (USA) - CytRx Corporation (USA) - deCODE Genetics (Iceland) - Deltagen, Inc (USA) - DevGen (Belgium) - Discovery Genomics, Inc (DGI) (USA) - Discovery Partners International, Inc (USA) - Eksigent Technologies LLC (USA) - Eli Lilly and Company (USA) - Entelos, Inc (USA) - Epigem Limited (UK) - EraGen Biosciences, Inc (USA) - Evident Technologies (USA) - Evotec AG (Germany) - Exelixis, Inc (USA) - Exonhit Therapeutics SA (France) - Fluorous Technologies, Inc (USA) - Galapagos NV (Belgium) - GE Healthcare Lifesciences (USA) - Gene Logic, Inc (USA) - Gene Network Sciences (USA) - Genstruct (USA) - Genzyme Corporation (USA) - GlaxoSmithKline (UK) - GPC Biotech AG (Germany) - Graffinity Pharmaceutical Design GmbH (Germany) - Gyros AB (Sweden) - H Lundbeck A/S (Denmark) - HistoRx, Inc (USA) - Human Genome Sciences, Inc (USA) - Hybrigenics SA (France) - Icagen, Inc (USA) - Iconix Pharmaceuticals (USA) - ICOS Corporation (USA) - Immusol, Inc (USA) - Incyte Corporation (USA) - Inpharmatica Ltd (UK) - Invitrogen Corporation (USA) - Karo Bio AB (Sweden) - KTEC (Kansas Technology Enterprise Corporation) (USA) - Lexicon Genetics, Inc (USA) - Ligand Pharmaceuticals (USA) - Lion Bioscience AG (Germany) - Living Cell Technologies Ltd (Australia) - Medarex, Inc (USA) - Memorec Stoffel GmbH (Germany) - Merck & Co, Inc (USA) - Millennium Pharmaceuticals Limited (UK) - Molecular Devices Corporation (USA) - Multicell Technologies, Inc (USA) - Nanostream, Inc (USA) - National Center for Drug Screening (China) - Neurogen Corporation (USA) - Novartis Institutes For Biomedical Research (NIBR) (USA) - Oncoimmunin, Inc (USA) - Origene Technologies, Inc (USA) - Palatin Technologies, Inc (USA) - Pall Corporation (USA) - PerkinElmer, Inc (USA) - Pharmacopeia, Inc (USA) - PharmaSeq, Inc (USA) - Physiomics PLC (UK) - Promega Corporation (USA) - Proteome Systems Limited (Australia) - Protiveris, Inc (USA) - Provid Pharmaceuticals, Inc (USA) - Qiagen NV (The Netherlands) - Quantum Pharmaceuticals (Russia) - Rigel Pharmaceuticals, Inc (USA) - SGX Pharmaceuticals, Inc (USA) - Shimadzu Corporation (Japan) - Sigma-Aldrich Corporation (USA) - Takeda Pharmaceutical Company Limited (Japan) - Tandem Labs (USA) - Tecan Group AG (Switzerland) - Tripos, Inc (USA) - UCB SA (Belgium) - Vertex Pharmaceuticals, Inc (USA) - Virogenomics, Inc (USA) - Xcellerex, Inc (USA) - Xenon Pharmaceuticals, Inc (USA) - Zyomyx, Inc (USA)

For more information visit http://www.researchandmarkets.com/reports/c41074